Gilles Laverny

2.5k total citations · 1 hit paper
38 papers, 1.8k citations indexed

About

Gilles Laverny is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Immunology. According to data from OpenAlex, Gilles Laverny has authored 38 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pathology and Forensic Medicine, 13 papers in Molecular Biology and 9 papers in Immunology. Recurrent topics in Gilles Laverny's work include Vitamin D Research Studies (11 papers), Muscle Physiology and Disorders (6 papers) and Mitochondrial Function and Pathology (4 papers). Gilles Laverny is often cited by papers focused on Vitamin D Research Studies (11 papers), Muscle Physiology and Disorders (6 papers) and Mitochondrial Function and Pathology (4 papers). Gilles Laverny collaborates with scholars based in France, Italy and United States. Gilles Laverny's co-authors include Luciano Adorini, Giuseppe Penna, Silvio Danese, Daniel Metzger, Saskia W. C. van Mil, Willem Renooij, Raffaella Maria Gadaleta, Leo W. J. Klomp, Bas Oldenburg and Karel J. van Erpecum and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Gilles Laverny

35 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease

2011 656 citations Raffaella Maria Gadaleta, Karel J. van Erpecum et al. Gut profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gilles Laverny France	19	627	401	359	349	313	38	1.8k
Weicheng Liu China	26	751 1.2×	301 0.8×	231 0.6×	496 1.4×	351 1.1×	82	2.4k
Hajime Isomoto Japan	26	601 1.0×	592 1.5×	232 0.6×	342 1.0×	550 1.8×	110	2.3k
Masayuki Saruta Japan	28	421 0.7×	491 1.2×	418 1.2×	515 1.5×	509 1.6×	154	2.3k
Toshiaki Nakano Japan	23	566 0.9×	401 1.0×	223 0.6×	451 1.3×	505 1.6×	132	2.2k
Seppo T. Nikkari Finland	27	730 1.2×	495 1.2×	236 0.7×	321 0.9×	233 0.7×	100	2.7k
Simone Carotti Italy	25	704 1.1×	863 2.2×	320 0.9×	200 0.6×	735 2.3×	69	2.5k
Matilde Bustos Spain	29	579 0.9×	492 1.2×	372 1.0×	474 1.4×	420 1.3×	59	2.2k
Ping Wen China	26	1.1k 1.8×	434 1.1×	207 0.6×	147 0.4×	388 1.2×	58	2.4k
Masataka Okuno Japan	28	862 1.4×	395 1.0×	339 0.9×	214 0.6×	489 1.6×	97	2.2k
Feng Zhou China	29	1.5k 2.3×	369 0.9×	286 0.8×	275 0.8×	739 2.4×	95	3.0k

Countries citing papers authored by Gilles Laverny

Since Specialization

Citations

This map shows the geographic impact of Gilles Laverny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilles Laverny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilles Laverny more than expected).

Fields of papers citing papers by Gilles Laverny

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilles Laverny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilles Laverny. The network helps show where Gilles Laverny may publish in the future.

Co-authorship network of co-authors of Gilles Laverny

This figure shows the co-authorship network connecting the top 25 collaborators of Gilles Laverny. A scholar is included among the top collaborators of Gilles Laverny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gilles Laverny. Gilles Laverny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Spinelli, Lionel, Lionel Chasson, Frédéric Di Fiore, et al.. (2025). Characterization of the immune landscape in healthy mouse prostate and during prostate cancer progression. OncoImmunology. 14(1). 2562220–2562220.

Keime, Céline, Tao Ye, Christelle Thibault-Carpentier, et al.. (2025). p53-loss induced prostatic epithelial cell plasticity and invasion is driven by a crosstalk with the tumor microenvironment. Cell Death and Disease. 16(1). 46–46. 2 indexed citations

Giannini, Margherita, Daniela Rovito, Mustapha Oulad‐Abdelghani, et al.. (2025). Experimental myositis: an optimised version of C-protein-induced myositis. RMD Open. 11(1). e004558–e004558.

Cai, Qingshuang, Céline Charvet, Tao Ye, et al.. (2024). LSD1 inhibition circumvents glucocorticoid-induced muscle wasting of male mice. Nature Communications. 15(1). 3563–3563. 7 indexed citations

Béraud, C, Anna Y. Belorusova, Yassmine Chebaro, et al.. (2024). A vitamin D‐based strategy overcomes chemoresistance in prostate cancer. British Journal of Pharmacology. 181(21). 4279–4293. 2 indexed citations

Peluso‐Iltis, Carole, Daniela Rovito, Judit Ősz, et al.. (2024). 4-Hydroxy-1α,25-Dihydroxyvitamin D3: Synthesis and Structure–Function Study. Biomolecules. 14(5). 551–551. 1 indexed citations

Zaloszyc, Ariane, Julie Bernardor, Justine Bacchetta, Gilles Laverny, & Claus Peter Schmitt. (2023). Mouse Models of Mineral Bone Disorders Associated with Chronic Kidney Disease. International Journal of Molecular Sciences. 24(6). 5325–5325. 7 indexed citations

Giannini, Margherita, Céline Keime, Daniela Rovito, et al.. (2023). OP0117 PROTEASOME INHIBITION AS A NEW TREATMENT FOR DERMATOMYOSITIS: RESULTS OF A DRUG REPURPOSING ANALYSIS BASED ON THE TRANSCRIPTOMIC SIGNATURE OF PATIENTS' PERIFASCICULAR FIBERS VALIDATED IN PRE-CLINICAL MODELS. Annals of the Rheumatic Diseases. 82. 77–77. 1 indexed citations

Belorusova, Anna Y., Daniela Rovito, Yassmine Chebaro, et al.. (2022). Vitamin D Analogs Bearing C-20 Modifications Stabilize the Agonistic Conformation of Non-Responsive Vitamin D Receptor Variants. International Journal of Molecular Sciences. 23(15). 8445–8445. 5 indexed citations

10.

Maaty, Mohamed A. Abu el, Céline Keime, Daniela Rovito, et al.. (2022). Hypoxia-mediated stabilization of HIF1A in prostatic intraepithelial neoplasia promotes cell plasticity and malignant progression. Science Advances. 8(29). eabo2295–eabo2295. 34 indexed citations

11.

Bacchetta, Justine, Thomas Édouard, Gilles Laverny, et al.. (2022). Vitamin D and calcium intakes in general pediatric populations: A French expert consensus paper. Archives de Pédiatrie. 29(4). 312–325. 41 indexed citations

12.

Maaty, Mohamed A. Abu el, Céline Keime, Justine Gantzer, et al.. (2021). Single-cell analyses unravel cell type–specific responses to a vitamin D analog in prostatic precancerous lesions. Science Advances. 7(31). 17 indexed citations

13.

Rovito, Daniela, Shilpy Joshi, Maxime Parisotto, et al.. (2021). Myod1 and GR coordinate myofiber-specific transcriptional enhancers. Nucleic Acids Research. 49(8). 4472–4492. 21 indexed citations

14.

Rovito, Daniela, Anna Y. Belorusova, Elvire Guiot, et al.. (2020). Cytosolic sequestration of the vitamin D receptor as a therapeutic option for vitamin D-induced hypercalcemia. Nature Communications. 11(1). 6249–6249. 22 indexed citations

15.

Laffont, Sophie, Eve Blanquart, Magali Savignac, et al.. (2017). Androgen signaling negatively controls group 2 innate lymphoid cells. The Journal of Experimental Medicine. 214(6). 1581–1592. 207 indexed citations

16.

Ramamoorthy, Thanuja Gali, Gilles Laverny, Anna-Isabel Schlagowski, et al.. (2015). The transcriptional coregulator PGC-1β controls mitochondrial function and anti-oxidant defence in skeletal muscles. Nature Communications. 6(1). 10210–10210. 61 indexed citations

17.

Lejay, Anne, Philippe Choquet, Fabien Thaveau, et al.. (2015). A New Murine Model of Sustainable and Durable Chronic Critical Limb Ischemia Fairly Mimicking Human Pathology. European Journal of Vascular and Endovascular Surgery. 49(2). 205–212. 26 indexed citations

18.

Huet, Tiphaine, Gilles Laverny, Fabrice Ciesielski, et al.. (2015). A Vitamin D Receptor Selectively Activated by Gemini Analogs Reveals Ligand Dependent and Independent Effects. Cell Reports. 10(4). 516–526. 41 indexed citations

19.

Pierrat, Philippe, Gilles Laverny, Gaëlle Creusat, et al.. (2013). Phospholipid–Detergent Conjugates as Novel Tools for siRNA Delivery. Chemistry - A European Journal. 19(7). 2344–2355. 20 indexed citations

20.

Gadaleta, Raffaella Maria, Karel J. van Erpecum, Bas Oldenburg, et al.. (2011). Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease. Gut. 60(4). 463–472. 656 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact